Zepp Health (NYSE:ZEPP) Insider Pengtao Yu Sells 4,251 Shares of Stock

Zepp Health Corporation Sponsored ADR (NYSE:ZEPP) insider Pengtao Yu sold 4,251 shares of the firm’s stock in a transaction dated Thursday, September 24th. The stock was sold at an average price of $4.09, for a total transaction of $17,386.59. Following the completion of the sale, the insider directly owned 98,491 shares of the company’s stock, valued at approximately $402,828.19. The trade was a 4.14% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Pengtao Yu also recently made the following trade(s):

• On Wednesday, September 23rd, Pengtao Yu sold 5,749 shares of Zepp Health stock. The shares were sold at an average price of $4.30, for a total value of $24,720.70.

Zepp Health Trading Up 0.3%

ZEPP opened at $4.13 on Friday. The company has a debt-to-equity ratio of 0.30, a quick ratio of 0.70 and a current ratio of 0.90. The stock’s 50 day moving average price is $4.86 and its 200-day moving average price is $8.48. Zepp Health Corporation Sponsored ADR has a one year low of $3.85 and a one year high of $61.85. The stock has a market cap of $60.64 million, a price-to-earnings ratio of -1.50 and a beta of 1.87.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in ZEPP. Monolith Management Ltd purchased a new position in Zepp Health during the 4th quarter valued at about $3,601,000. Engineers Gate Manager LP lifted its position in shares of Zepp Health by 44.4% in the 2nd quarter. Engineers Gate Manager LP now owns 20,917 shares of the company’s stock worth $109,000 after purchasing an additional 6,433 shares during the period. AXQ Capital LP purchased a new stake in shares of Zepp Health in the 2nd quarter worth approximately $85,000. Finally, Harvest Fund Management Co. Ltd boosted its stake in shares of Zepp Health by 6.7% during the fourth quarter. Harvest Fund Management Co. Ltd now owns 44,800 shares of the company’s stock valued at $1,207,000 after purchasing an additional 2,800 shares in the last quarter. 52.61% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several equities analysts have commented on the company. Fundamental Research set a $53.01 price objective on Zepp Health and gave the company a “buy” rating in a research report on Tuesday, August 11th. Wall Street Zen downgraded Zepp Health from a “hold” rating to a “sell” rating in a research report on Tuesday, September 8th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Zepp Health in a research note on Tuesday, September 8th. One research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Zepp Health presently has a consensus rating of “Hold” and an average target price of $53.01.

Zepp Health Company Profile

Zepp Health Corporation (NYSE: ZEPP) is a wearable technology company that develops smart health and fitness devices, along with digital platforms and services designed to help consumers monitor and improve their wellness. Its products collect and analyze information such as activity, sleep, heart rate and other health-related metrics.

The company’s principal consumer brand is Amazfit, which offers smartwatches, fitness trackers and related accessories. Zepp Health also operates the Zepp brand of digital health software and services and has introduced products and services focused on areas such as sleep and hearing health.